ArticleCancers2023

Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE).

Esther Natalie Oliva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.